Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arnulf Ferlitsch

Showing results (1-10 of 91) with videos related to

Pageof 10
Sort By:
Clinical Liver Disease|April 18, 2019
Liver Biopsy-TransjugularRémy Schwarzer, Arnulf Ferlitsch
Gastrointestinal Endoscopy|October 5, 2014
Endoscopic imaging of the vermiform appendix (with video)Arnulf Ferlitsch, Andreas Puespoek, Christoph Gasche
European Journal of Case Reports in Internal Medicine|December 12, 2022
Chylous Ascites as the Main Clinical Symptom of a <i>Strongyloides stercoralis</i> Infection in an Immigrant from Bosnia-HerzegovinaLukas Antonitsch, Daniela Penz, Arnulf Ferlitsch
Visceral Medicine|October 23, 2018
Management of Coagulopathy during Bleeding and Invasive Procedures in Patients with Liver FailureAndreas Drolz, Arnulf Ferlitsch, Valentin Fuhrmann
The American Journal of Gastroenterology|May 7, 2013
Response to Shaikh et alMonika Ferlitsch, Christina Bannert, Arnulf Ferlitsch
Hepatology (Baltimore, Md.)|January 30, 2013
Reply: To PMID 22532296Monika Ferlitsch, Markus Peck-Radosavljevic, Arnulf Ferlitsch
Alimentary Pharmacology & Therapeutics|September 25, 2018
Editorial: surviving your genes-the role of PNPLA3 variation in end-stage liver disease. Authors' replyMattias Mandorfer, Bernhard Scheiner, Thomas Reiberger, et al.
The Journal of Clinical Endocrinology and Metabolism|May 10, 2007
Altered platelet plug formation in hyperthyroidism and hypothyroidismMonika Homoncik, Alois Gessl, Arnulf Ferlitsch, et al.
World Journal of Urology|May 7, 2014
Lower urinary tract symptoms in patients with liver cirrhosisMarkus Margreiter, Birgit B Heinisch, Remy Schwarzer, et al.
Plos One|February 20, 2016
The VITRO Score (Von Willebrand Factor Antigen/Thrombocyte Ratio) as a New Marker for Clinically Significant Portal Hypertension in Comparison to Other Non-Invasive Parameters of Fibrosis Including ELF TestStephanie Hametner, Arnulf Ferlitsch, Monika Ferlitsch, et al.
Pageof 10

Showing results (1-10 of 91) with videos related to

Sort By:
Pageof 10
Clinical Liver Disease|April 18, 2019
Liver Biopsy-TransjugularRémy Schwarzer, Arnulf Ferlitsch
Gastrointestinal Endoscopy|October 5, 2014
Endoscopic imaging of the vermiform appendix (with video)Arnulf Ferlitsch, Andreas Puespoek, Christoph Gasche
European Journal of Case Reports in Internal Medicine|December 12, 2022
Chylous Ascites as the Main Clinical Symptom of a <i>Strongyloides stercoralis</i> Infection in an Immigrant from Bosnia-HerzegovinaLukas Antonitsch, Daniela Penz, Arnulf Ferlitsch
Visceral Medicine|October 23, 2018
Management of Coagulopathy during Bleeding and Invasive Procedures in Patients with Liver FailureAndreas Drolz, Arnulf Ferlitsch, Valentin Fuhrmann
The American Journal of Gastroenterology|May 7, 2013
Response to Shaikh et alMonika Ferlitsch, Christina Bannert, Arnulf Ferlitsch
Hepatology (Baltimore, Md.)|January 30, 2013
Reply: To PMID 22532296Monika Ferlitsch, Markus Peck-Radosavljevic, Arnulf Ferlitsch
Alimentary Pharmacology & Therapeutics|September 25, 2018
Editorial: surviving your genes-the role of PNPLA3 variation in end-stage liver disease. Authors' replyMattias Mandorfer, Bernhard Scheiner, Thomas Reiberger, et al.
The Journal of Clinical Endocrinology and Metabolism|May 10, 2007
Altered platelet plug formation in hyperthyroidism and hypothyroidismMonika Homoncik, Alois Gessl, Arnulf Ferlitsch, et al.
World Journal of Urology|May 7, 2014
Lower urinary tract symptoms in patients with liver cirrhosisMarkus Margreiter, Birgit B Heinisch, Remy Schwarzer, et al.
Plos One|February 20, 2016
The VITRO Score (Von Willebrand Factor Antigen/Thrombocyte Ratio) as a New Marker for Clinically Significant Portal Hypertension in Comparison to Other Non-Invasive Parameters of Fibrosis Including ELF TestStephanie Hametner, Arnulf Ferlitsch, Monika Ferlitsch, et al.
Pageof 10